Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 9, 2014, Pages 2912-2915

  Boyraz, İsmail ^a   Koç, Bünyamin ^a   Boyacı, Ahmet ^b   Tutoğlu, Ahmet ^b   Sarman, Hakan ^a   Özkan, Hilal ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Inflammation; Marker; Neutrophil

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; HEMOGRAM TEST; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; PLATELET LYMPHOCYTE RATIO; RETROSPECTIVE STUDY;

EID: 84907829263     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ren L, Li J, Luo R, Tang R, Zhu S, Wan L. Efficacy of antitumor necrosis factor alpha agents on patients with ankylosing spondylitis. Am J Med Sci 2013; 346: 455-461.
2. Braun J, Sieper J. Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches. Arthritis Res 2002; 4: 307-21.
3. Zink A, Braun J, Listing J, Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis results fromthe German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000; 27: 613-22.
4. Ward MM. Health related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999; 12: 247-55.
5. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38: 499-505.
6. Wooley PH, Dutcher J, Widmer MB, Gillis S. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 1993; 151: 6602-7.
7. Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M, Acarturk G. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 2013; 36: 1357-62.
8. Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2011; 7: 105-12.
9. Balta S, Demirkol S, Unlu M, Arslan Z, Celik T. Neutrophil to lymphocyte ratio may be predict of mortality in all conditions. Br J Cancer 2013 Dec 10; 109: 3125-6.
10. Demir M. The relationship between neutrophil lymphocyte ratio and non-dipper hypertension. Clin Exp Hypertens 2013; 35: 570-3.
11. Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, Emoto M, Shoji T, Tahara H, Inaba M, Hino M, Shioi A, Miki T, Nishizawa Y. Platelet P-selectin expression is associated with atherosclerotic Wall thickness in carotid artery in humans. Circulation 2003; 108: 524-9.
12. Borissoff JI, Spronk HM, Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2013; 364: 1746-60.
13. Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 2001; 19: 143-51.
14. Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, Demirtas L, Turk S, Tonbul HZ. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int 2013; 17: 391-6.
15. Toben D, Schroeder I, El Khassawna T, Mehta M, Hoffmann JE, Frisch JT, Schell H, Lienau J, Serra A, Radbruch A, Duda GN. Fracture healing is accelerated in the absence of the adaptive immune system. J Bone Miner Res 2011; 26: 113-24.
16. Ozturk ZA, Yesil Y, Kuyumcu ME, Bilici M, Ozturk N, Yeşil NK, Ozkaya M, Kısacık B, Kepekci Y, Arıogul S. Inverse relationship between neutrophil lymphocyte ratio (NLR) and bone mineral density (BMD) in elderly people. Arch Gerontol Geriatr 2013; 57: 81-5.
17. Uslu AU, Deveci K, Korkmaz S, Aydin B, Senel S, Sancakdar E, Sencan M. Is neutrophil/lymphocyteratioassociatedwithsubclinicalinflammationandamyloidosis in patientswithfamilialMediterraneanfever? Biomed Res Int 2013; 2013: 185317.
18. Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 2007; 65: 318-24.